Pathogenesis of Liver Fibrosis
The DOI matches its Crossref record; 220 of the 222 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral hepatitis and, more recently, from fatty liver disease associated with obesity. Hepatic stellate cell activation represents a critical event in fibrosis because these cells become the primary source of extracellular matrix in liver upon injury. Use of cell-culture and animal models has expanded our understanding of the mechanisms underlying stellate cell activation and has shed new light on genetic regulation, the contribution of immune signaling, and the potential reversibility of the disease. As pathways of fibrogenesis are increasingly clarified, the key challenge will be translating new advances into the development of antifibrotic therapies for patients with chronic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“STAT3, a member of the STATs family, is a key transcriptional mediator of cellular processes [43, 44].”
From Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation (2025) · cites this paper as [43]
In the citing paper
“they may also derive from portal fibroblasts, bone marrow-derived cells, circulating fibrocytes, [7] and by the controversially discussed epithelial-tomesenchymal (EMT) [8,9] or endothelial-to-mesenchymal (EndoTM) transition.[10,11]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [7]
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Origins and Mechanisms of miRNAs and siRNAs
Carthew, R. W., & Sontheimer, E. J. (2009) · Cell · doi:10.1016/j.cell.2009.01.035 · Cited by 5,018
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Self-citationMany roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Self-citationEndothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Bendelac, A., Savage, P. B., & Teyton, L. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,155
Research works printed but not linked: 15
- 10.1172/jci200112373 · DOI · Paper page
- 10.1055/s-2001-17556 · DOI · Paper page
- Stupack DG., 2007, Oncology, 21, 6
- Hehlgans S, 2007, Biochim. Biophys. Acta, 1775, 163
- Omenetti A, 2008, J. Clin. Investig., 118, 3331
- Pinzani M, 1996, Am. J. Pathol., 148, 785
- Sims DE., 1991, Can. J. Cardiol., 7, 431
- Thimgan MS, 1999, Am. J. Physiol., 277, G137
- 10.1136/gut.2005.088690 · DOI · Paper page
- Gao B., 2005, Cell Mol. Immunol., 2, 92
- Anania FA, 1995, Hepatology, 21, 1640
- Connolly MK, 2009, J. Clin. Investig., 119, 3213
- Seki E, 2009, J. Clin. Investig., 119, 1858
- McCrudden R, 2000, Histol. Histopathol., 15, 1159
- 10.1002/hep.23046 · DOI · Paper page
Cited by
Items 801–900 of 1,007
Li, Y., Shang, W., Liang, X., Zeng, C., Liu, M., Wang, S., Li, H., & Tian, J. (2018) · RSC Advances · doi:10.1039/c7ra10847h · Cited by 25
Sasa veitchii extract protects against carbon tetrachloride-induced hepatic fibrosis in mice
Yoshioka, H., Nonogaki, T., Fukaya, S., Ichimaru, Y., Nagatsu, A., Yoshikawa, M., Fujii, H., & Nakao, M. (2018) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-018-0739-7 · Cited by 24
Chen, Z., Yao, L., Liu, Y., Pan, Z., Peng, S., Wan, G., Cheng, J., Wang, J., & Cao, W. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8047 · Cited by 24
Zhao, X., Chen, G.-M., Liu, Y., Chen, Y., Wu, H., Chen, J., Xiong, Y., Tian, C., Wang, G., Jia, B., et al. (2017) · PubMed Central · Cited by 24
Ni, M., Wang, L., Yu, H., Wen, X., Yang, Y., Liu, G., Hu, Y., & Li, Z. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27391 · Cited by 24
“cirrhosis and other complications, including portal hypertension and liver failure.(2) Patients with cirrhosis are at high risk to develop hepatocellular carcinoma.”
BackgroundSong, M. S., Zhang, H., Chen, Z., Yang, J. X., Li, J., Shao, S., & Liu, J. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9460 · Cited by 24
Sepúlveda‐Crespo, D., Resino, S., & Martínez, I. (2021) · Drugs · doi:10.1007/s40265-020-01458-x · Cited by 24
Wu, C., Cheng, D., Peng, Y., Li, Y., Fu, C., Wang, Y. X., Fu, L., Peng, S., & Ni, X. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.683506 · Cited by 24
“It has been documented that the activation of hepatic stellate cells (HSCs) through various inflammatory and fibrogenic pathways plays a pivotal role in liver fibrosis (4, 5).”
BackgroundShu, Y., Xu, Q. R., Xu, Y., Tao, Q., Shao, M., Cao, X., Chen, Y., Wu, Z., Chen, M., Zhou, Y., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04263-w · Cited by 24
Th17 cells in the liver: balancing autoimmunity and pathogen defense
Taniki, N., Nakamoto, N., Chu, P., Ichikawa, M., Teratani, T., & Kanai∥, T. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00917-9 · Cited by 24
“Once activated, HSCs express alpha smooth muscle actin (α-SMA) and produce a large quantity of collagen, leading to liver fibrosis [202].”
BackgroundNadaf, L. A., Kamareddine, M. H., Fayad, E., Hussain, A., & Farhat, S. G. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i4.744 · Cited by 24
Song, X., Shi, J., Liu, J., Liu, Y., Yu, Y., Qiu, Y., Cao, Z., Pan, Y., Yuan, X., Chu, Y., et al. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00508-2 · Cited by 24
“Liver fibrosis is a reversible pathological response, and timely reversal of liver fibrosis can prevent chronic liver disease from progressing to cirrhosis and liver cancer (Hernandez-Gea and Friedman 2011).”
BackgroundLiver Fibrosis: A Clinical Update
Shipley, L. C., Axley, P. D., & Singal, A. K. (2019) · EMJ Hepatology · doi:10.33590/emjhepatol/10313576 · Cited by 25
Tibaldi, E. V., Zonta, F., Bordin, L., Magrin, E., Gringeri, E., Cillo, U., Idotta, G., Pagano, M. A., & Brunati, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.10.010 · Cited by 24
Cheng, J.-C., Tseng, C., Liao, M.-H., Peng, C., Yu, J., Chuang, P., Huang, J.-T., & Chen, J. J. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-04259-7 · Cited by 24
Zhao, L., Shi, M., Zhou, L., Sun, H., Zhang, X., He, L., Tang, Z., Wang, C., Wu, Y., Chen, T., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006251 · Cited by 24
Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell
Zhang, H., Sun, D., Wang, G., Cui, S., Field, R. A., Li, J. X., & Zang, Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.065 · Cited by 24
Bai, T., Yao, Y., Jin, X., Lian, L., Li, Q., Yang, N., Jin, Q., Wu, Y., & Nan, J. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.04.016 · Cited by 24
Knockdown of miR-23, miR-27, and miR-24 alters fetal liver development and blocks fibrosis in mice
Rogler, C. E., Matarlo, J. S., Kosmyna, B., Fulop, D., & Rogler, L. E. (2017) · Gene Expression · doi:10.3727/105221616x693891 · Cited by 23
Nanomedicines in the Treatment of Liver Fibrosis: A Review
Du, X., Niu, R., Liu, X., Wu, F., Yang, X., Ma, X., Zhang, J., Zhou, H.-H., Shao, L., & Wang, S. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s524078 · Cited by 23
“13 Thus, activated HSCs are crucial targets for LF treatment.”
Debes, J. D., de Knegt, R. J., & Boonstra, A. (2016) · Transplantation · doi:10.1097/tp.0000000000001623 · Cited by 23
KRT17 Promotes the Activation of HSCs via EMT in Liver Fibrosis
Chen, J., Ge, S.-J., Feng, H.-J., Wu, S.-Z., Ji, R., Huang, W.-R., Huang, W., & Lu, C.-H. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00101 · Cited by 23
A high-throughput technique to map cell images to cell positions using a 3D imaging flow cytometer
Zhang, Z., Tang, R. H., Chen, X., Waller, L., Kau, A., Fung, A. A., Gutierrez, B., An, C., Cho, S. H., Shi, L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118068119 · Cited by 23
The S100 calcium binding protein A11 promotes liver fibrogenesis by targeting TGF-β signaling
Zhu, T., Zhang, L., Li, C., Tan, X., Liu, J., Li, H., Fan, Q., Zhang, Z., Zhan, M., Fu, L., et al. (2022) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2022.02.013 · Cited by 23
Yuan, Z., Wang, J., Zhang, H., Chai, Y., Xu, Y., Miao, Y., Yuan, Z., Zhang, L., Jiang, Z., & Yu, Q. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110508 · Cited by 23
Klaus, J. B., Goerke, U., Klarhöfer, M., Keerthivasan, M., Jung, B. A., Berzigotti, A., Ebner, L., Roos, J. E., Christe, A., Obmann, V. C., et al. (2024) · Investigative Radiology · doi:10.1097/rli.0000000000001084 · Cited by 23
Chi, K. Y., Kim, G., Kim, H., Kim, H., Jo, S., Lee, J., Lee, Y., Yoon, H., Cho, S.-H., Kim, J., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122898 · Cited by 23
Role of cytokine receptor-like factor 1 in hepatic stellate cells and fibrosis
Stefanovic, L., & Stefanovic, B. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i12.356 · Cited by 23
Targeted TFO delivery to hepatic stellate cells
Yang, N., Singh, S. P., & Mahato, R. I. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.037 · Cited by 23
Hepatoprotective effects of Limonium tetragonum, edible medicinal halophyte growing near seashores
Jeong, E. J., Yang, M., Kim, N.-H., Heo, J., & Sung, S. H. (2014) · Pharmacognosy Magazine · doi:10.4103/0973-1296.139783 · Cited by 23
Hazem, S. H., Shaker, M. E., Ashamallah, S. A., & Ibrahim, T. M. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.06.017 · Cited by 23
Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1
Kandhi, R., Bobbala, D., Yeganeh, M., Mayhue, M., Menéndez, A., & Ilangumaran, S. (2015) · Cytokine · doi:10.1016/j.cyto.2015.12.007 · Cited by 23
Khalifa, Y. H., Mourad, G. M., Stephanos, W. M., Omar, S. A. M., & Mehanna, R. A. (2019) · BioMed Research International · doi:10.1155/2019/5376165 · Cited by 23
“e consequence of progressive fibrosis is cirrhosis, which often leads to the development of hepatocellular carcinoma (HCC) and endstage liver failure within a period of 20 to 40 years [2].”
BackgroundPredicting the stages of liver fibrosis with multiphase CT radiomics based on volumetric features
Cui, E., Long, W., Wu, J., Li, Q., Ma, C., Yi, L., & Lin, F. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03051-6 · Cited by 23
Hui, S. T. Y., Wang, F., Stappenbeck, F., French, S. W., Magyar, C. E., Parhami, F., & Lusis, A. J. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.296 · Cited by 23
Aoudjehane, L., Bisch, G., Scatton, O., Granier, C., Gaston, J., Housset, C., Roingeard, P., Cosset, F., Perdigão, F., Balladur, P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134141 · Cited by 23
Feng, G., Zhang, J., Zeng, Q., Yu, X., Zhang, Z., Lv, S., Xu, X., & Wang, F. (2013) · Hepatology Research · doi:10.1111/hepr.12215 · Cited by 23
Paulsen, D., Urban, A., Knorr, A., Hirth‐Dietrich, C., Siegling, A., Volk, H., Mercer, A. A., Limmer, A., Schumak, B., Knolle, P. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074605 · Cited by 23
Liu, T., Wang, P., Cong, M., Zhang, D., Liu, L., Li, H., Zhai, Q., Li, Z., Jia, J., & You, H. (2016) · Bioscience Reports · doi:10.1042/bsr20160111 · Cited by 23
Kim, S. M., Choi, J. E., Hur, W., Kim, J., Hong, S. W., Lee, E. B., Lee, J. H., Li, T. Z., Sung, P. S., & Yoon, S. K. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25776 · Cited by 23
Alteration of Trace Elements during Pathogenesis of N-Nitrosodimethylamine Induced Hepatic Fibrosis
George, J., Tsutsumi, M., & Tsuchishima, M. (2019) · Scientific Reports · doi:10.1038/s41598-018-37516-4 · Cited by 23
Zhang, C., An, R., Bao, Y., Meng, X., Wang, T., Sun, H., Pan, F., & Zhang, C. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.055 · Cited by 23
Atanasova, I. P., Sojoodi, M., Leitão, H. S., Shuvaev, S., Geraldes, C. F. G. C., Masia, R., Guimarães, A. R., Tanabe, K. K., Fuchs, B. C., & Caravan, P. D. (2019) · Investigative Radiology · doi:10.1097/rli.0000000000000631 · Cited by 23
Mutanen, A., Lohi, J., Sorsa, T. A., Jalanko, H., & Pakarinen, M. P. (2016) · Surgery · doi:10.1016/j.surg.2016.04.025 · Cited by 22
Zhang, H., Xiong, Y., Yang, C., Zhan, Q., Fu, Y., Luo, H., & Luo, H. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13352 · Cited by 22
Lu, S., Zhao, H., Zhou, Y., & Xu, F. (2021) · Pharmacology · doi:10.1159/000516892 · Cited by 22
Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling
Xiao, Z., Ji, Q., Fu, Y., Gao, S., Hu, Y., Liu, W., Chen, G., Mu, Y., Chen, J., & Liu, P. (2021) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-021-3304-y · Cited by 22
Cytoskeleton alterations in non-alcoholic fatty liver disease
Pessoa, J., & Teixeira, J. (2021) · Metabolism · doi:10.1016/j.metabol.2021.155115 · Cited by 22
Ding, X., Zhu, X., Xu, D., Li, S., Yang, Q., Feng, X., Wei, Y.-G., Li, H., Yang, L., Zhang, Y.-J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06043-0 · Cited by 22
“The factors that activate HSCs include platelet-derived growth factor, transforming growth factor (TGF-β), tumor necrosis factor, and interleukin (IL) [10].”
BackgroundAldaba-Muruato, L. R., Moreno, M. G., Shibayama, M., Tsutsumi, V., & Muriel, P. (2013) · Pharmacology · doi:10.1159/000339078 · Cited by 22
Immunological Orchestration of Liver Fibrosis
Tanaka, H., Leung, P. S. C., Kenny, T. P., Gershwin, M. E., & Bowlus, C. L. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8323-1 · Cited by 24
Zhang, X., Xin, J., Shi, Y., Xu, W., Yu, S., Yang, Z., Liu, C., Cao, L., & Guo, Q. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.11.007 · Cited by 22
Epigenetic regulation in cardiac fibrosis
Yu, L., & Xu, Y. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i11.784 · Cited by 22
Zhang, F., Zhang, M., Wang, A., Xu, M., Wang, C., Xu, G., Zhang, B., Zou, X., & Zhuge, Y. (2016) · Cell Biology International · doi:10.1002/cbin.10706 · Cited by 22
Yu, J. H., Kim, J. M., Kim, J. K., Choi, S. J., Lee, K. S., Lee, J., Chang, H. Y., & Lee, J. I. (2017) · Oncotarget · doi:10.18632/oncotarget.17134 · Cited by 22
Hu, J.-P., Zhang, R., Tang, M., Li, Y., Xun, L., Shi, Z., An, Y., Li, T., & Song, Z. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0098-9 · Cited by 22
α-Lipoic acid modulates liver fibrosis: A cross talk between TGF-β1, autophagy, and apoptosis
El-Maadawy, W. H., Hammam, O. A., el-Din, S. H. S., & El-Lakkany, N. M. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119891212 · Cited by 22
“autophagy appears to be one of the critical contributors.(6) Autophagy is an important conserved process needed to maintain intracellular energy balance.”
BackgroundHuang, W., Zheng, Y., Feng, H., Ni, L., Ruan, Y.-F., Zou, X., Ye, M., & Zou, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109932 · Cited by 22
Xu, X., Zhu, H., Li, R., Lin, H., Grimm, R., Fu, C., & Yan, F. (2020) · European Radiology · doi:10.1007/s00330-020-07235-4 · Cited by 22
Xue, F., Lu, J., Buchl, S. C., Sun, L., Shah, V. H., Malhi, H., & Maiers, J. L. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00453.2020 · Cited by 22
Yin, J., Quan, W., Kong, X., Liu, C., Lu, B., & Lin, W. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00130 · Cited by 22
ASIC1a promotes hepatic stellate cell activation through the exosomal miR-301a-3p/BTG1 pathway
Luan, S., Yang, Y.-Q., Ye, M.-P., Liu, H., Rao, Q.-F., Kong, J.-L., & Wu, F.-R. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.05.041 · Cited by 22
Ferreira, A. G. K., da Cunha, A. A., Machado, F. R., Pederzolli, C. D., Dalazen, G. R., de Assis, A. M., Lamers, M. L., dos Santos, M. F., Dutra‐Filho, C. S., & Wyse, Â. T. D. S. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23342 · Cited by 22
Wettere, A. J. V., Law, J. M., Hinton, D. E., & Kullman, S. W. (2012) · Toxicologic Pathology · doi:10.1177/0192623312464308 · Cited by 22
Cordie, A., Salama, A., Elsharkawy, M., El‐Nahaas, S. M., Khairy, M., Elsharkawy, A. M., Hassany, M., & Esmat, G. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25064 · Cited by 22
Collagen-targeted MRI contrast agent for liver fibrosis detection
Kennedy, P., & Taouli, B. A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0266-z · Cited by 22
Rafiei, H., Yeung, M., Kowalski, S., Krystal, G., & Elisia, I. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1234300 · Cited by 21
Lin, A., Xiong, M., Tang, B., Jiang, A., Shen, J., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2025) · Hepatology International · doi:10.1007/s12072-025-10838-y · Cited by 21
“In this process, the original type IV collagen within the space of Disse is progressively replaced by fibrillar type I and type III collagens, culminating in the formation of fibrotic scar tissue, which eventually leads to liver cirrhosis [42, 43].”
Quercetin Reduces Hepatic Fibrogenesis by Inhibiting TGF-β/Smad3 Signaling Pathway in LX-2 Cell Line
Shakerian, E., Akbari, R., Mohammadtaghvaei, N., Gahrooie, M. M., & Afarin, R. (2021) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.5812/jjnpp.113484 · Cited by 21
Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells
Li, Y., Kim, M., Park, Y., & Lee, J. (2021) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2021.100245 · Cited by 21
Chen, X., Hu, G., He, B., Cao, Z., He, J., Luo, H., Li, Y., & Yu, Q. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116142 · Cited by 21
Zhu, X., Zhou, Z., & Pan, X. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1342356 · Cited by 22
Zhang, L., Deng, W., Wang, X., Huang, Q., Liang, S., Ding, Z., Qi, L., Wang, Y., Zhou, T., Xing, L., et al. (2024) · Advanced Science · doi:10.1002/advs.202408898 · Cited by 21
Wang, Q., Tao, Y.-Y., Shen, L., Cui, H.-Y., & Liu, C.-H. (2012) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20120512 · Cited by 21
Wen, S., Feng, S., Tang, S., Gao, J., Zhang, L.-H., Tong, H., Yan, Z., & Fang, D. Z. (2016) · Scientific Reports · doi:10.1038/srep35426 · Cited by 21
Hepatic SATB1 induces paracrine activation of hepatic stellate cells and is upregulated by HBx
Gong, J., Tu, W., Han, J., He, J., Liu, J., Han, P., Wang, Y., Li, M., Liu, M., Liao, J., et al. (2016) · Scientific Reports · doi:10.1038/srep37717 · Cited by 21
Feng, X., Zhong, G.-J., Ba, D. J. D., Yang, B., Chen, L., & Du, S. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13568 · Cited by 21
Role of the S100 protein family in liver disease (Review)
Yao, S., Yang, X., An, J., Jin, H. D., Wen, G., Wang, H., & Tuo, B. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4999 · Cited by 21
Mahdinloo, S., Hemmati, S., Valizadeh, H., Mahmoudian, M., Mahmoudi, J., Roshangar, L., Sarfraz, M., & Zakeri‐Milani, P. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122063 · Cited by 21
Liu, P., Wang, B., Sun, M., Long, A.-H., Cao, H., Ren, S., Bian, Y., Lu, X., Gu, H.-T., & Liu, C. (2015) · Pharmacognosy Magazine · doi:10.4103/0973-1296.153098 · Cited by 21
“[3] Although it is recognized that hepatic stellate cells (HSCs) play a pivotal role in fibrogenesis,[4,5] other liver residential cells like Kupffer cells or cholangiocytes have an important role, particularly in bile salt mediated fibrosis.”
BackgroundHall, R. A., Liebe, R., Hochrath, K., Kazakov, A., Alberts, R., Laufs, U., Böhm, M., Fischer, H., Williams, R. W., Schughart, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089279 · Cited by 21
“A characteristic feature of the fibrotic response is the ongoing repair mechanism resulting in an excessive accumulation of extracellular matrix [1,2].”
BackgroundBML-11, A Lipoxin Receptor Agonist, Protected Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats
Zhou, X., Yu, Z., Yan, D., Wang, H., Huang, Y., Sha, J., Xu, F., Cai, Z., & Min, W. (2013) · Inflammation · doi:10.1007/s10753-013-9643-x · Cited by 21
Depletion of β‐arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway
Sun, W., Song, Y., Hu, S., Wang, Q., Wu, H., Chen, J., & Wei, W. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24458 · Cited by 21
Li, X., Chen, H., Yi, Z., Yanming, L., & Jianping, G. (2017) · Oncotarget · doi:10.18632/oncotarget.15472 · Cited by 21
MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice
Hong, J.-S., Lee, D.-H., Yook, Y. W., Na, D., Jang, Y. J., Kim, J., & Lee, Y. S. (2017) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2017.1308242 · Cited by 21
The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis
Bao, S., Zheng, J., & Shi, G. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7044 · Cited by 21
Leptin up-regulates microRNA-27a/b-3p level in hepatic stellate cells
Li, Z., Li, J., Su, S., Zhu, X., Cheng, F., Jia, X., Zhou, Q., & Zhou, Y. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.03.015 · Cited by 21
Villar-Lorenzo, A., Rada, P., Rey, E., Marañón, P., Arroba, A. I., Santamaría, B., Sáiz, J., Rupérez, F. J., Barbas, C., García‐Monzón, C., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.038810 · Cited by 21
“Because of this, the hepatic parenchyma is progressively replaced by fibrotic scar tissue (Hernandez-Gea and Friedman, 2011; Pinzani and Luong, 2018).”
Tsai, M., Yen, Y., Chang, K., Hung, C., Chen, C., Lin, M., & Hu, T. (2019) · BMC Cancer · doi:10.1186/s12885-019-6397-3 · Cited by 21
Estrogen receptor 1 signaling in hepatic stellate cells designates resistance to liver fibrosis
Li, T., Wang, G., Zhao, H., Liu, F., Deng, Z., Chen, D., Zhou, X., Cao, Y., Fu, W., Zhang, H., et al. (2025) · Cell Discovery · doi:10.1038/s41421-025-00783-3 · Cited by 20
Darwish, O. I., Gharib, A. M., Jeljeli, S., Metwalli, N. S., Feeley, J., Rotman, Y., Brown, R. J., Ouwerkerk, R., Kleiner, D. E., Stäb, D., et al. (2023) · Investigative Radiology · doi:10.1097/rli.0000000000000952 · Cited by 20
Eukaryotic Ribosomal Protein S5 of the 40S Subunit: Structure and Function
Qiu, L., Chao, W., Zhong, S., & Ren, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043386 · Cited by 20
Roles of X-box binding protein 1 in liver pathogenesis
Tak, J., Kim, Y. S., & Kim, S. G. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0441 · Cited by 20
Terzioğlu, D., Uslu, L., Şimşek, G., Atukeren, P., Erman, H., Gelışgen, R., Ayvaz, S., Aksu, B., & Uzun, H. (2016) · Journal of Investigative Surgery · doi:10.1080/08941939.2016.1257666 · Cited by 20
Stellate Cells and Hepatic Fibrosis
Hasegawa, D., Wallace, M. C., & Friedman, S. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00004-x · Cited by 21
Self-citationAdel, N., Mantawy, E. M., Elsherbiny, D. A., & El‐Demerdash, E. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114748 · Cited by 20
Lu, W., Gao, Y. H., Wang, Z.-Z., Cai, Y. S., Yang, Y., Miao, Y. Q., Pei, F., Liu, X., & Zhuang, H. (2017) · PubMed Central · doi:10.3760/cma.j.issn.1007-3418.2017.04.005 · Cited by 20
Lan, T., Zhuang, L., Li, S., Yang, G., Xuan, Y., & Guo, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110586 · Cited by 20
Tariq, S., Landry, K. B., Malik, A. M., Rehman, S., Ijaz, B., & Shahıd, A. A. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113938 · Cited by 20
Chen, Z., Xiao, H., Ye, X., Liu, K., Rios, R. S., Zheng, K. I., Jin, Y., Targher, G., Byrne, C. D., Shi, J., et al. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-23 · Cited by 20
Metadata
- Authors
- Hernandez-Gea, V., & Friedman, S. L.
- Affiliations
- Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029;
- Icahn School of Medicine at Mount Sinai (US)
- ORCID
- Friedman, Scott L.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 425-456
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2142988890
- Cited by
- 1,809
- References
- 220
- Citations by year
- 2026: 81 · 2025: 123 · 2024: 121 · 2023: 112 · 2022: 148 · 2021: 174 · 2020: 145 · 2019: 119 · 2018: 117 · 2017: 131 · 2016: 136 · 2015: 124 · 2014: 97 · 2013: 76 · 2012: 67
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, hepatic stellate cell activation, extracellular matrix, chronic viral hepatitis, hepatic steatosis, obesity, immune signaling, genetic control, fibrosis reversibility, antifibrotic therapy, chronic liver disease
- MeSH terms
- Humans, Liver, Liver Cirrhosis, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.